Chanwit Roongsritong is a Cardiology physician. OpenAlex indexes 60 publications with 2,063 citations (h-index 16); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E 2nd St
Suite 400
Reno, NV 895021262
Telephone
775-982-2400Provider last certified this registry record 12 May 2021.
Clinical trials
- "SVEAT" Chest Pain Scoring System
Sponsor: University of Nevada, Reno
- Study to Determine Racial and Gender Differences in Platelet Aggregation
Sponsor: Texas Tech University Health Sciences Center
- Association of PICP Serum Marker in Patients With LVSD
Sponsor: Texas Tech University Health Sciences Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Recor Medical IncProgram year20251 payment
- ABIOMEDProgram year20251 payment
- Boston Scientific CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.5%Beta blocker22%Carvedilol65%Metoprolol Succinate35%Part D<11 patientsStatin14.7%Atorvastatin Calcium100%Part D≥17 patients+ 4 more classes in this area
Blood & clotting
19.2%P2Y12 inhibitor13.1%Clopidogrel100%Part D≥11 patientsFactor Xa inhibitor6.1%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
5.3%SGLT2 inhibitor5.3%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”